Paragraph IV Challenges CLE: Exploring 2017 Trends

To learn more about this webcast please visit our website:

Since its enactment, the Hatch-Waxman Act has been continuously encouraging generic drug manufacturers to challenge active drug patent and gain market entry before the patents’ expected nominal expiration dates.

In the past years, the number of lawsuits involving paragraph IV challenges has significantly increased and the outcome of each litigation varies significantly according to the type of patent challenged.

In this LIVE Webcast, a team of thought leaders and professionals brought together by The Knowledge Group will provide the audience with an in-depth analysis of all the important issues and trends surrounding Paragraph IV challenges. Speakers will also present key strategies and practical tips to avoid common risks and pitfalls surrounding this significant topic.

Key topics include:

Paragraph IV Challenges in the 2017 Landscape
Recent Court Decisions
Scope and Limitations
Common Risks and Pitfalls
Recent Trends, Developments, and Updates